Replies to post #180574 on Biotech Values

[jq1234]

>> people in this trial had failed rituxan

People can be treated with Rituxan based therapies multiple times because Rituxan retreatment has activity not only as monotherapy but also in combination. See recent ph3 from GILD's Idelalisib in combination with Rituxan for rrCLL:

http://www.nejm.org/doi/full/10.1056/NEJMoa1315226